All in all, further studies will be required to validate our preliminary findings and to address these concerns together with more research targeting the TLR4-IRF5 axis to evaluate its therapeutic significance in obesity/T2D. Here, IRF5 is linked to obesity due to melanocortin 4 receptor deficiency.